Pioneering work in cancer detectionCell based biomarkers
Founded in 2009, XZELL has leveraged Single Cell PathologyTM to become the leader in early, pain-free cancer detection.
We are dedicated to develop our technologies to detect all cancers possible, as early as possible. This is reflected in our growing number of clinical study sites currently covering prostate, endometrial, ovarian, breast, colorectal and bile duct cancer, as well as in our continuously growing patent portfolio.
Our TeamTHE BEST AND BRIGHTEST
Sebastian Chakrit Punyaratabandhu Bhakdi
hMX Cell Separation, MSc
Quality Management, MSc
Get In Touch
Use the form below to contact us for more information.